Start Filing Your ITR Now
Our plans start from ₹ 499/-

Astec LifeSciences Limited Share Price Target From 2025 to 2030

Astec LifeSciences Limited, part of the Godrej Agrovet Group, is a leading manufacturer of agrochemicals and pharmaceutical intermediates in India. With a strong focus on research, innovation, and global exports, the company has established itself as a key player in the specialty chemicals sector.

In this article, we will explore Astec LifeSciences’ share price targets from 2025 to 2030, along with essential insights for investors.


Astec LifeSciences Share Price Today (As of August 2025)

Detail Value
Current Price ₹819.90
Previous Close ₹819.35
Day's High ₹920.00
Day's Low ₹815.50
52-Week High ₹1,333.50
52-Week Low ₹634.60
Market Capitalization ₹2,010 Cr
Beta (Volatility) 0.70
Book Value per Share ₹212.00
Face Value ₹10
All-Time High ₹2,288.80
All-Time Low ₹13.85

About Astec LifeSciences Limited

Founded in 1994 and later acquired by Godrej Agrovet, Astec LifeSciences Limited manufactures agrochemical active ingredients, intermediates, and formulations. The company serves both domestic and international markets, with a strong presence in the US, Europe, and Latin America.

Key Highlights:

  • Strong parentage under Godrej Group.

  • Diversified product portfolio in fungicides, herbicides, and pharmaceutical intermediates.

  • Export-driven growth with 60%+ revenue from overseas.

  • R&D focus for introducing high-margin specialty chemicals.

  • Conservative beta (0.70), suggesting lower volatility compared to peers.


Astec LifeSciences Shareholding Pattern (August 2025)

Investor Type Holding (%)
Promoters 72.42%
Retail & Others 23.55%
Mutual Funds 4.01%
Foreign Institutions 0.02%

This shareholding pattern indicates strong promoter confidence, with retail participation also being significant.


Astec LifeSciences Share Price Target 2025 to 2030

Year Minimum Target (₹) Maximum Target (₹)
2025 850 930
2026 970 1,080
2027 1,120 1,280
2028 1,300 1,520
2029 1,480 1,720
2030 1,700 2,000

These projections are based on market growth trends, financial performance, sector expansion, and global demand for agrochemicals.


Year-Wise Analysis & Investment Advice

✅ Astec LifeSciences Share Price Target 2025: ₹850 – ₹930

Astec is expected to show steady performance in 2025, supported by stable demand for agrochemicals and cost optimization.

Why?

  • Strong monsoon-driven agriculture demand.

  • Increasing global exports.

  • Lower volatility due to low beta (0.70).

Investment Advice: Good time for staggered entry.


✅ Astec LifeSciences Share Price Target 2026: ₹970 – ₹1,080

In 2026, the company could benefit from higher export realizations and new product launches.

Why?

  • Focus on high-value fungicides.

  • Strategic expansion in Europe.

  • Better margins from backward integration.

Investment Advice: Hold for long-term compounding returns.


✅ Astec LifeSciences Share Price Target 2027: ₹1,120 – ₹1,280

The year 2027 may bring strong financial results, supported by innovation in R&D.

Why?

  • Introduction of niche agrochemical molecules.

  • Higher demand in October-November agriculture season.

  • Improved operating profit margins.

Investment Advice: Reinvest dividends; maintain portfolio weightage.


✅ Astec LifeSciences Share Price Target 2028: ₹1,300 – ₹1,520

By 2028, Astec could witness strong earnings growth.

Why?

  • Sustainable agrochemical products gaining traction.

  • Strong balance sheet and increasing book value per share.

  • Growth in pharmaceutical intermediates.

Investment Advice: Continue investing for CAGR returns.


✅ Astec LifeSciences Share Price Target 2029: ₹1,480 – ₹1,720

Exports and new markets may help Astec expand significantly in 2029.

Why?

  • Growing demand in Latin America.

  • Stable promoter holding.

  • Consistent growth in net profit.

Investment Advice: Ideal for long-term investors.


✅ Astec LifeSciences Share Price Target 2030: ₹1,700 – ₹2,000

By 2030, Astec could become a major player in the global agrochemical segment.

Why?

  • Diversification across agrochemicals and pharma intermediates.

  • Strong R&D focus.

  • Rising agricultural demand globally.

Investment Advice: Excellent for wealth creation and portfolio diversification.


Should You Invest in Astec LifeSciences for the Long Term?

Yes. Astec LifeSciences shows strong fundamentals, promoter backing, and growing demand for agrochemicals, making it a good long-term bet.

Key Reasons to Invest:

  • Strong promoter holding (72.42%).

  • Diversified export-driven growth.

  • Consistent book value increase.

  • Low beta stock, less volatile compared to peers.

⚠️ Risks to Watch Out For:

  • Dependency on agrochemical demand cycles.

  • Regulatory restrictions in key markets.

  • Commodity price volatility.


Conclusion

Astec LifeSciences Limited is a fundamentally strong company with robust promoter backing from the Godrej Group. With its presence in both domestic and global markets, strong R&D capabilities, and a healthy balance sheet, Astec offers promising opportunities for long-term investors.

Currently trading around ₹819.90, analysts believe the stock has potential to reach ₹2,000 by 2030. For investors seeking growth in the specialty chemicals and agrochemicals sector, Astec LifeSciences can be a solid portfolio choice.


Frequently Asked Questions (FAQs) about Astec LifeSciences

1. What is the current share price of Astec LifeSciences?
The current share price is around ₹819.90 (August 2025).

2. What is the share price target for Astec LifeSciences in 2025?
The 2025 share price target is between ₹850 – ₹930.

3. Is Astec LifeSciences a good buy now?
Yes, given its promoter backing, low volatility, and export-driven growth, it’s considered a good long-term buy.

4. What is Astec LifeSciences’ all-time high and low?
All-time high: ₹2,288.80; All-time low: ₹13.85.

5. Should I invest in Astec LifeSciences for the long term?
Yes, especially if you’re looking for exposure in agrochemicals and specialty chemicals.


???? Disclaimer: This article is for educational purposes only. Please consult a certified financial advisor before investing.

author

The Tax Heaven

Mr.Vishwas Agarwal✍📊, a seasoned Chartered Accountant 📈💼 and the co-founder & CEO of THE TAX HEAVEN, brings 10 years of expertise in financial management and taxation. Specializing in ITR filing 📑🗃, GST returns 📈💼, and income tax advisory. He offers astute financial guidance and compliance solutions to individuals and businesses alike. Their passion for simplifying complex financial concepts into actionable insights empowers readers with valuable knowledge for informed decision-making. Through insightful blog content, he aims to demystify financial complexities, offering practical advice and tips to navigate the intricate world of finance and taxation.

Subscribe to the exclusive updates!